Microtek Medical Holdings, Inc. Sustainability Profile
Microtek Medical Holdings, Inc., headquartered in the United States, is a prominent player in the medical device industry, specialising in innovative solutions for healthcare providers. Founded in 1991, the company has established itself as a leader in the development and manufacturing of advanced medical products, particularly in the fields of wound care and surgical instruments. With a strong operational presence across North America and Europe, Microtek Medical is renowned for its commitment to quality and safety. The company’s core offerings include a range of sterile and non-sterile medical supplies, designed to enhance patient outcomes and streamline clinical workflows. Notably, Microtek's unique approach to product design and functionality has garnered recognition within the healthcare community, solidifying its market position as a trusted provider of essential medical solutions.
DitchCarbon Score
How does Microtek Medical Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Rubber and Plastic Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Microtek Medical Holdings, Inc.'s score of 90 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Microtek Medical Holdings, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Ecolab Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation. As part of its corporate family relationship with Ecolab Inc., Microtek Medical Holdings may align with various sustainability initiatives and targets set by Ecolab. These include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded down from Ecolab Inc. at a level 1 relationship. However, specific reduction targets or achievements for Microtek Medical Holdings are not detailed. In summary, while Microtek Medical Holdings, Inc. does not currently report its own emissions data or specific climate commitments, it is positioned within a corporate structure that prioritises sustainability and may benefit from the climate initiatives of its parent company, Ecolab Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 396,916,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 289,712,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,919,965,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Microtek Medical Holdings, Inc.'s Industry?
How Carbon Intensive is Microtek Medical Holdings, Inc.'s Location?
Microtek Medical Holdings, Inc.'s Scope 3 Categories Breakdown
Microtek Medical Holdings, Inc.'s Scope 3 emissions, which increased by 12% last year and increased by approximately 13% since 2015, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 66% of Scope 3 emissions.
Top Scope 3 Categories
Microtek Medical Holdings, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Microtek Medical Holdings, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.